In breast adenocarcinoma cells after 48 h of RNAi silencing, TRPM2 levels were decreased more than 75% in the MCF-7 cell line (Fig. 1C) and ~80% in the MDA-MB-231 cell line (Fig. 1D) as compared to control levels. This evidence concerns the gene TRPM2 and breast adenocarcinoma.